Verrica Pharmaceuticals Inc (VRCA) — Capital Reinvestment Ratio

Latest as of September 2022: 0.04x

Verrica Pharmaceuticals Inc (VRCA) has a Capital Reinvestment Ratio of 0.04x as of September 2022, meaning it reinvests 0% of its operating cash flow ($1.82 Million) in capital expenditures ($77.00K). See Verrica Pharmaceuticals Inc (VRCA) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

$1.82 Million

USD

Capital Expenditures

$77.00K

USD

Data as of

Sep 2022

Most recent filing

Annual Capital Reinvestment Ratio for Verrica Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Verrica Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see VRCA market cap.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow